Abstract
The objective of the present study was to examine several dimensions of quality of life (QoL) and fatigue in patients with adrenal incidentaloma. This was a case–control study designed to analyze patient outcomes using three validated generic QoL questionnaires, EQ-5D, SF-36, and MFI-20, the results of which were compared to those obtained for age- and sex-matched controls. The study population comprised 139 consecutive patients with nonfunctioning adrenal masses (104 females, 35 males; age 59.1 ± 10.8) and 139 age- and sex-matched controls. Reduced QoL was found in patients with adrenal incidentaloma as compared to controls. Dimensions of QoL that were notably affected included mobility (P = 0.03), performance of usual activities (P = 0.002), and anxiety/depression (P = 0.04) as evaluated using the EQ-5D; physical functioning (P < 0.001), physical role (P < 0.001), general health (P < 0.001), vitality (P = 0.001), social functioning (P = 0.001), and emotional role (P < 0.001) as evaluated using the SF-36; and physical fatigue (P = 0.04) as assessed using the MFI-20 questionnaire. In addition, perceived health on a visual analogue scale was also significantly lower in patients than in controls (64.8 ± 19.2 vs. 77.1 ± 15.1; P < 0.001). Patients with adrenal incidentaloma reported reduced QoL and a higher level of physical fatigue compared to age- and sex-matched controls. This subject will benefit from further studies comparing QoL outcomes of laparoscopic adrenalectomy versus no treatment in patients with adrenal incidentaloma.
Similar content being viewed by others
References
M.M. Grumbach, B.M. Biller, G.D. Braunstein, K.K. Campbell, J.A. Carney, P.A. Godley, E.L. Harris, J.K. Lee, Y.C. Oertel, M.C. Posner, J.A. Schlechte, H.S. Wieand, Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann. Intern. Med. 138, 424–429 (2003)
R.T. Kloos, M.D. Gross, I.R. Francis, M. Korobkin, B. Shapiro, Incidentally discovered adrenal masses. Endocr. Rev. 16, 460–484 (1995)
M. Terzolo, A. Pia, A. Ali, G. Osella, G. Reimondo, S. Bovio, F. Daffara, M. Procopio, P. Paccotti, G. Boretta, A. Angeli, Adrenal incidentaloma: a new cause of the metabolic syndrome? J. Clin. Endocrinol. Metab. 87, 998–1003 (2002)
L. Tauchmanovà, R. Rossi, B. Biondi, M. Pulcrano, V. Nuzzo, E.A. Palmieri, S. Fazio, G. Lombardi, Patients with subclinical Cushing’s syndrome due to adrenal adenoma have increased cardiovascular risk. J. Clin. Endocrinol. Metab. 87, 4872–4878 (2002)
M. Torlontano, I. Chiodini, M. Pileri, G. Guglielmi, M. Cammisa, S. Modoni, V. Carnevale, V. Trischitta, A. Scillitani, Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. J. Clin. Endocrinol. Metab. 84, 2381–2385 (1999)
I. Chiodini, M. Torlontano, V. Carnevale, G. Guglielmi, M. Cammisa, V. Trischitta, A. Scillitani, Bone loss rate in adrenal incidentalomas: a longitudinal study. J. Clin. Endocrinol. Metab. 86, 5337–5341 (2001)
W.F. Young, The incidentally discovered adrenal mass. N. Engl. J. Med. 356, 601–610 (2007)
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26, S5–S20 (2003)
V. Morelli, B. Masserini, A.S. Salcuni, C. Eller-Vainicher, C. Savoca, R. Viti, F. Coletti, G. Guglielmi, C. Battista, L. Iorio, P. Beck-Peccoz, B. Ambrosi, M. Arosio, A. Scilitani, I. Chiodini, Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects. Clin. Endocrinol. 73, 161–166 (2010)
R. Rabin, EQ-5D: a measure of health status from the EuroQoL group. Ann. Med. 33, 337–343 (2001)
J.E. Ware, B. Gandek, Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J. Clin. Epidemiol. 51, 903–912 (1998)
E.M. Smets, B. Garssen, B. Bonke, J.C. de Haes, The Multidimensional Fatigue Inventory (MFI): psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 39, 315–325 (1995)
G. Osella, M. Terzolo, G. Borretta, G. Magro, A. Ali, A. Piovesan, P. Paccotti, A. Angeli, Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). J. Clin. Endocrinol. Metab. 79, 1532–1539 (1994)
R. Libe, C. Dall’Asta, L. Barbetta, A. Baccarelli, P. Beck-Peccoz, B. Ambrosi, Long-term follow-up study of patients with adrenal incidentalomas. Eur. J. Endocrinol. 147, 489–494 (2002)
L. Barzon, C. Scaroni, N. Sonino, F. Fallo, A. Paoletta, M. Boscaro, Risk factors and long-term follow-up of adrenal incidentalomas. J. Clin. Endocrinol. Metab. 84, 520–526 (1999)
F. Mantero, M. Terzolo, G. Arnaldi, G. Osella, A.M. Masini, A. Alì, M. Giovagnetti, G. Opocher, A. Angeli, A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J. Clin. Endocrinol. Metab. 85, 637–644 (2000)
S.M. Webb, X. Badia, M.J. Barahona, A. Colao, C.J. Strasburger, A. Tabarin, M.O. van Aken, R. Pivonello, G. Stalla, S.W.J. Lamberts, J.E. Glusman, Evaluation of health-related quality of life in patients with Cushing’s syndrome with a new questionnaire. Eur. J. Endocrinol. 158, 623–630 (2008)
N. Sukor, C. Kogovsek, R.D. Gordon, D. Robson, M. Stowasser, Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. J. Clin. Endocrinol. Metab. 95, 1360–1364 (2010)
M.D. Johnson, C.J. Woodburn, M.L. Vance, Quality of life in patients with pituitary adenoma. Pituitary 6, 81–87 (2003)
E.H. Nielsen, J. Lindholm, P. Laurberg, P. Bjerre, J.S. Christiansen, C. Hagen, S. Juul, J. Jorgensen, A. Kruse, K. Stochholm, Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function. Pituitary 10, 67–73 (2007)
A.A. van der Klaauw, M. Kars, N.R. Biermasz, F. Roelfsema, O.M. Dekkers, E.P. Corssmit, M.O. van Aken, B. Havekes, A.M. Pereira, H. Pijl, J.W. Smit, J.A. Romijn, Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin. Endocrinol. 69, 775–784 (2008)
O.M. Dekkers, A.A. van der Klaauw, A.M. Pereira, N.R. Biermasz, P.J. Honkoop, F. Roelfsema, J.W. Smit, J.A. Romijn, Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J. Clin. Endocrinol. Metab. 91, 3364–3369 (2006)
Acknowledgment
The study was funded by Research Program No. 108-0000000-3496 of the Croatian Ministry of Science, Education and Sport.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kastelan, D., Dzubur, F., Dusek, T. et al. Health-related quality of life and fatigue in patients with adrenal incidentaloma. Endocrine 40, 84–89 (2011). https://doi.org/10.1007/s12020-011-9456-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-011-9456-3